ALEMBIC PHARMACEUTICALS LTD. (APLLTD)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,332.27 1,478.84 1,588.39 1,474.55 1,475.56 1,580.35 1,406.09 1,570.64 1,494.17 1,796.24 1,642.24 1,718.74
YOY Revenue Growth % 14.82% 9.19% 21.23% 12.81% 10.75% 6.86% -11.48% 6.52% 1.26% 13.66% 16.8% 9.43%
Other Income 11.84 8.95 3.30 7.22 3.15 16.06 15.46 13.21 7.79 11.49 10.73 25.88
Total Income 1,344.12 1,487.80 1,591.69 1,481.78 1,478.70 1,596.41 1,421.55 1,583.85 1,501.96 1,807.73 1,652.97 1,744.62
Total Expenses + 1,083.79 1,215.78 1,076.23 1,102.41 1,201.45 1,241.95 1,294.86 1,492.29 1,376.44 1,591.38 1,471.96 1,546.40
Cost of Materials Consumed 334.19 413.87 317.58 337.38 405.93 393.14 446.91 426.20 431.27 463.14 448.73 404.24
Employee Benefit Expense 327.47 326.41 327.11 354.92 356.51 367.61 369.18 373.27 396.40 408.12 401.36 407.02
Other Expenses 422.13 475.50 431.53 410.11 439.01 481.20 478.78 476.92 466.76 500.90 464.59 522.72
Operating Profit 248.49 263.07 512.17 372.14 274.10 338.40 111.22 78.35 117.73 204.86 170.28 172.34
OPM % 18.7% 17.8% 32.2% 25.2% 18.6% 21.4% 7.9% 5% 7.9% 11.4% 10.4% 10%
Profit Before Tax + 97.53 133.84 256.70 216.16 213.20 200.02 103.81 91.56 125.52 216.35 138.78 173.46
Tax Expense 0.00 0.00 23.46 14.29 37.01 34.24 18.00 16.22 22.00 36.99 24.31 -69.61
Tax % 0% 0% 9.1% 6.6% 17.4% 17.1% 17.3% 17.7% 17.5% 17.1% 17.5% -40.1%
Profit After Tax 97.53 133.84 233.24 201.87 176.19 165.78 85.81 75.34 103.52 179.36 114.47 243.07
EPS (Basic) 4.96 6.81 11.87 10.27 8.96 8.43 4.37 3.83 5.27 9.12 5.82 12.37

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 6,032.63 5,874.06 5,149.00 4,996.61 5,051.44 4,132.55 3,660.27
YOY Revenue Growth % 2.7% 14.08% 3.05% -1.09% 22.24% 12.9% -
Other Income 47.88 31.32 3.55 49.98 9.73 134.75 6.42
Total Income 6,080.51 5,905.38 5,152.54 5,046.58 5,061.18 4,267.31 3,666.69
Total Expenses + 5,484.79 4,478.20 4,074.61 3,570.38 3,357.01 2,861.90 2,631.56
Cost of Materials Consumed 1,672.17 1,403.01 1,250.08 1,111.75 1,175.71 978.13 850.05
Employee Benefit Expense 1,466.57 1,335.91 1,094.82 1,028.18 948.27 806.37 684.45
Other Expenses 1,875.90 1,739.28 1,729.71 1,430.45 1,233.03 1,077.40 1,097.06
Operating Profit 547.84 1,395.86 1,074.39 1,426.22 1,694.44 1,270.65 1,028.71
OPM % 9.1% 23.8% 20.9% 28.5% 33.5% 30.7% 28.1%
Profit Before Exceptional 595.72 704.23 345.93 908.45 1,416.60 1,176.79 764.63
Exceptional Items 12.87 0.00 0.00 0.00 0.00 -10.00 0.00
Profit Before Tax + 608.59 704.23 345.93 908.45 1,416.60 1,166.79 764.63
Tax Expense 105.47 37.75 -0.80 114.45 241.21 197.39 153.42
Tax % 17.3% 5.4% -0.2% 12.6% 17% 16.9% 20.1%
Profit After Tax 503.12 666.48 346.73 794.00 1,175.39 969.41 611.21
EPS (Basic) 25.60 33.91 17.64 40.39 60.67 51.42 32.42

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 3,790.07 3,409.99 3,350.20 0.00 0.00 0.00 0.00
Property, Plant & Equipment 2,513.47 2,535.66 2,377.45 0.00 0.00 0.00 0.00
Capital Work in Progress 837.23 524.36 601.28 0.00 0.00 0.00 0.00
Non-Current Investments 259.56 226.68 229.27 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 3,766.20 2,988.55 2,780.22 0.00 0.00 0.00 0.00
Inventories 1,976.34 1,353.07 1,275.13 0.00 0.00 0.00 0.00
Trade Receivables 1,480.67 1,340.12 1,201.20 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 14.23 20.13 21.67 0.00 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 39.31 39.31 39.31 0.00 0.00 0.00 0.00
Other Equity 5,155.43 4,869.60 4,374.98 0.00 0.00 0.00 0.00
Non-Current Liabilities 161.93 162.42 164.83 0.00 0.00 0.00 0.00
Current Liabilities 2,199.60 1,327.21 1,551.29 0.00 0.00 0.00 0.00
Total Liabilities 2,361.53 1,489.63 1,716.12 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 226.57 772.77 730.25 621.15 0.00 0.00 0.00
Cash from Investing Activities -636.08 -329.02 -460.98 -447.36 0.00 0.00 0.00
Cash from Financing Activities 403.61 -445.29 -261.16 -216.13 0.00 0.00 0.00
Net Increase/Decrease in Cash -5.90 -1.54 8.11 -42.34 0.00 0.00 0.00